miR-508 sustains phosphoinositide signalling and promotes aggressive phenotype of oesophageal squamous cell carcinoma.
about
miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesisRegulation of PI3K effector signalling in cancer by the phosphoinositide phosphatasesMicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulationDifferential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic CancermiR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.miR‑150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma.MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.Phosphatidylinositolphosphate phosphatase activities and cancer.Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis.Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.Flotilin-1 promotes the tumorigenicity and progression of malignant phenotype in human lung adenocarcinoma.SH2B1 promotes epithelial-mesenchymal transition through the IRS1/β-catenin signaling axis in lung adenocarcinoma.Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis
P2860
Q28384791-7A52B943-EE6F-4E5A-94FF-8BDC245E6D96Q29248612-0E561DAA-BDB6-4D4F-AC33-2DB758351D79Q35742539-BC648B38-401F-4006-AF9E-CE3F8E0D3C8CQ36498615-54284CFD-A1CC-46EB-BB3F-68559B66FEDCQ36830338-DBEC13E4-7F3A-42F9-8C01-8D4D65732C3DQ37697139-87714303-78A6-4750-BC67-5172DD5D7B55Q37718685-C6C9902A-C2B2-4649-B19A-590E3295C4CCQ37739814-D978B2EB-3524-4CD0-B9A0-FEB94BA2A3CAQ38572786-0BF41BD4-4609-4E70-9B3E-29C489278D2AQ39237748-73A403D8-C987-4E62-9170-605E53B7A97CQ42647010-06947874-6977-459B-BAB2-D095B2225229Q47927238-8E4AA558-1794-4461-9005-BD3CED6CA787Q48520033-A292CF75-AC46-4752-9190-1B32D02B5D0AQ58695588-8842351D-1350-4CF8-9E9C-C762663019C8
P2860
miR-508 sustains phosphoinositide signalling and promotes aggressive phenotype of oesophageal squamous cell carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
miR-508 sustains phosphoinosit ...... ageal squamous cell carcinoma.
@en
miR-508 sustains phosphoinosit ...... ageal squamous cell carcinoma.
@nl
type
label
miR-508 sustains phosphoinosit ...... ageal squamous cell carcinoma.
@en
miR-508 sustains phosphoinosit ...... ageal squamous cell carcinoma.
@nl
prefLabel
miR-508 sustains phosphoinosit ...... ageal squamous cell carcinoma.
@en
miR-508 sustains phosphoinosit ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P356
P1476
miR-508 sustains phosphoinosit ...... hageal squamous cell carcinoma
@en
P2093
Jinrong Zhu
Jueheng Wu
Libing Song
Mengfeng Li
Pengli Ren
P2860
P2888
P356
10.1038/NCOMMS5620
P407
P577
2014-08-06T00:00:00Z